Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years

By sjmartinez • January 6, 2024

Charles-Schoeman C, Giles JT, Lane NE, Choy E, Furst DE, Vencovský J, Wilson AG, Burmester GR, Coombs D, Penn SK, Khan N, Yee JB, Rahawi K, McInnes IB. Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatol Ther. 2024 Jan 5. doi: 10.1007/s40744-023-00624-3. Epub ahead of print. PMID: 38180720.

Tags: JAK inhibitor, Laboratory parameters, Publications, Rheumatoid arthritis, Rheumatology, Upadacitinib

Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease

Prueksapraopong C, Fernandes A, Campo Fernandez B, Roy S, Hollis RP, Habtemariam B, Pellin D, Ceoldo G, Lin TY, Dang TT, Cornetta K, Romero Z,[...]

A climate region classification for California’s warm season: apparent temperature clustering to support heat-health epidemiology

Villanueva M, Monte-Sano S, Sheridan S, Allen M, Kalkstein L, Jerrett M, Eisenman DP. A climate region classification for California's warm season: apparent temperature clustering[...]

The Natural History of Chronic Lung Allograft Dysfunction in Single and Bilateral Orthotopic Lung Transplant Recipients

M Lari S, Kim J, Zhou J, Sayah DM, Der Hovanessian A, Saggar R, Shino MY, Ramsey A, Turner GA, Amubieya O, Ardehali A, Kulkarni[...]